Correction: Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease

Affiliations

• ¹ Division of Hematology, The Ottawa Hospital, Ottawa, ON, Canada.
• ² Department of Data Sciences, Dana-Farber Cancer Institute, Harvard School of Public Health, Boston, MA, USA.
• ³ Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
• ⁴ Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA, USA.
• ⁵ Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. [email protected].